| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/08/1998 | EP0833628A1 Novel taxoids |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0715624B1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | CN1178534A Isolated nucleic acid molecules as members of the Mage-Xp family and uses thereof |
| 04/08/1998 | CN1178528A 10 -deacetylbaccatine III and 10 -deacetyl 14 'beta' -hydroxybaccatine III derivatives, process for preparation thereof and pharmaceutical compositions containing them |
| 04/08/1998 | CN1178521A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/08/1998 | CN1178466A Antitumor agents comprising as the principal agent compounds |
| 04/08/1998 | CN1037966C Production of 4 -(5, 6, 7, 8 -tetrahydroimidazo £1.5-a| pyridine -5 -group) benzonitrile acidified hemihydrate |
| 04/07/1998 | US5736578 Treatment of sleep disorders |
| 04/07/1998 | US5736563 Transcutaneous in vivo activation of photosensitive agents in blood |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736542 Pharmaceutical compositions containing a staurosporine |
| 04/07/1998 | US5736539 Inhibitors of farnesyl-protein transferase |
| 04/07/1998 | US5736534 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
| 04/07/1998 | US5736366 Adsorption of 10-deacetylbaccatin iii from aqueous suspension of ground yew plant (taxus sp.), desorption from substrate by solvent, desolventizing and selective crystallization |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736154 Multilayered, intra-lesional, interferon delivery which doesn't pass into blood stream; for treatuble carcinomas |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA2154871C Farnesyl:protein transferase inhibitors as anticancer agents |
| 04/07/1998 | CA2018229C Carboplatin composition |
| 04/07/1998 | CA1339803C Dideoxydidehydrocarbocyclic nucleosides |
| 04/07/1998 | CA1339798C Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 04/03/1998 | CA2216265A1 Method for inhibiting the growth of mammalian cells |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013385A2 Non-naturally occurring lipoprotein particle |
| 04/02/1998 | WO1998013379A1 METHOD OF CELL INHIBITION USING POLYPEPTIDES DERIVED FROM THE VENOM OF THE AUSTRIALIAN JUMPER ANT $i(MYRMECIA PILOSULA) |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013358A1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013045A1 Cancerous metastasis inhibitors containing uracil derivatives |
| 04/02/1998 | DE19640207A1 Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung) Glycoconjugates of modified camptothecin derivatives (A or B ring junction) |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2814748A1 O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates |
| 04/02/1998 | CA2705474A1 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 04/02/1998 | CA2267332A1 Methods for culturing cells |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2266336A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 04/02/1998 | CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/01/1998 | EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832653A1 Use of cytokines and cytotoxic compounds in a method for treatment of tumours |
| 04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832190A1 Essential oligonucleotides of vertebrate telomerase |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832104A1 Novel dolastatin derivatives, their preparation and use |
| 04/01/1998 | EP0832101A2 Urethane mediated, gst specific molecular release systems |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832094A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832081A1 Bicyclic-aromatic compounds |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832073A1 Quinazolines and pharmaceutical compositions |
| 04/01/1998 | EP0832063A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/01/1998 | EP0832060A1 Chalcone retinoids and methods of use of same |
| 04/01/1998 | EP0832057A1 Diaromatic propynyl or dienyl compounds |
| 04/01/1998 | EP0831939A1 Structurally determined metallo-constructs and applications |
| 04/01/1998 | EP0831938A1 Radiolabeled peptide compositions for site-specific targeting |
| 04/01/1998 | EP0831936A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 04/01/1998 | EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/01/1998 | EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831895A1 Tumor associated epitopes |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 04/01/1998 | EP0831855A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 04/01/1998 | EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
| 04/01/1998 | EP0831850A1 Use of locally applied dna fragments |
| 04/01/1998 | EP0831849A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 04/01/1998 | EP0831839A1 Use of vitamin d4 derivatives for treating cancer |
| 04/01/1998 | EP0831838A1 Use of vitamin d 4? derivatives for treating skin disorders |
| 04/01/1998 | EP0831831A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
| 04/01/1998 | EP0831829A1 Heterocyclic ring-fused pyrimidine derivatives |
| 04/01/1998 | EP0831819A1 Method for inhibiting neoplastic disease in mammals |